Humphrey Gardner
Chief Tech/Sci/R&D Officer chez HBM HOLDINGS LIMITED
Profil
Humphrey A.
R.
Gardner is currently the Chief Medical Officer at HBM Holdings Ltd.
and a Member of the American Society of Clinical Oncology, Inc. He previously held positions as Senior Vice President-Clinical Development at Karyopharm Therapeutics, Inc., Chief-Medical Oncology at Evelo Biosciences, Inc., Chief Medical Officer at Silicon INSITE, Inc., and Chief Medical Officer at Harbour BioMed (Shanghai) Co., Ltd.
He also served as Global Chief Medical Officer at Medicenna Therapeutics Corp.
from 2023 to 2024.
Gardner received his undergraduate and doctorate degrees from the University of Cambridge and a graduate degree from Brandeis University.
Postes actifs de Humphrey Gardner
| Sociétés | Poste | Début |
|---|---|---|
| HBM HOLDINGS LIMITED | Chief Tech/Sci/R&D Officer | 14/04/2022 |
American Society of Clinical Oncology, Inc.
 American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Corporate Officer/Principal | - |
Anciens postes connus de Humphrey Gardner
| Sociétés | Poste | Fin |
|---|---|---|
| MEDICENNA THERAPEUTICS CORP. | Chief Tech/Sci/R&D Officer | 14/02/2024 |
Harbour BioMed (Shanghai) Co., Ltd.
 Harbour BioMed (Shanghai) Co., Ltd. BiotechnologyHealth Technology Harbour Biomed Shanghai Co. Ltd. engages in the development of therapeutics for cancer, especially in immuno-oncology. The company is headquartered in Shanghai, China. | Chief Tech/Sci/R&D Officer | - |
Silicon INSITE, Inc.
 Silicon INSITE, Inc. BiotechnologyHealth Technology Silicon Therapeutics LLC operates as an integrated computational drug discovery company that focuses on developing novel medicines for diseases. Its INSITE platform closely represents the dynamical nature of targets using all-atom simulations. The firm has offices in Boston and Shanghai. The company was founded by Lijun Sun, Peiqi Sun, Elliot L. Chaikof, and Finith Jernigan, III in 2016 and is headquartered in Boston, MA. | Chief Tech/Sci/R&D Officer | - |
| EVELO BIOSCIENCES, INC. | Corporate Officer/Principal | - |
| KARYOPHARM THERAPEUTICS INC. | Corporate Officer/Principal | - |
Formation de Humphrey Gardner
| University of Cambridge | Doctorate Degree |
| Brandeis University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| KARYOPHARM THERAPEUTICS INC. | Health Technology |
| EVELO BIOSCIENCES, INC. | Health Technology |
| MEDICENNA THERAPEUTICS CORP. | Health Technology |
| HBM HOLDINGS LIMITED | Health Technology |
| Entreprise privées | 3 |
|---|---|
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Health Services |
Silicon INSITE, Inc.
Silicon INSITE, Inc. BiotechnologyHealth Technology Silicon Therapeutics LLC operates as an integrated computational drug discovery company that focuses on developing novel medicines for diseases. Its INSITE platform closely represents the dynamical nature of targets using all-atom simulations. The firm has offices in Boston and Shanghai. The company was founded by Lijun Sun, Peiqi Sun, Elliot L. Chaikof, and Finith Jernigan, III in 2016 and is headquartered in Boston, MA. | Health Technology |
Harbour BioMed (Shanghai) Co., Ltd.
Harbour BioMed (Shanghai) Co., Ltd. BiotechnologyHealth Technology Harbour Biomed Shanghai Co. Ltd. engages in the development of therapeutics for cancer, especially in immuno-oncology. The company is headquartered in Shanghai, China. | Health Technology |
